Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis
Susannah J. King(La Trobe University), Tom Kotsimbos(Alfred Health), Eldho Paul(Monash Health), Brigitte M. Borg(The Alfred Hospital), D. Keating(Alfred Health), Brenda Button(The Alfred Hospital), E. Williams(The Alfred Hospital), John Wilson(Vanderbilt University), F. Finlayson(The Alfred Hospital)
Cited by 18
Related Papers
Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2016|452
Longitudinal weight gain in women identified With polycystic ovary syndrome: Results of an observational study in young women
|Obesity|2013|349
Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases
|European Respiratory Journal|2018|214
Risk factors for gestational diabetes mellitus: Implications for the application of screening guidelines
|Australian and New Zealand Journal of Obstetrics and Gynaecology|2011|202